Annovis Bio Inc at ThinkEquity Conference Transcript
(audio in progress) accounting advisory firm, and we help companies with their financial reporting, accounting, valuation, and HR needs, and specialize assisting companies navigate the capital markets.
It's my pleasure to introduce you to Dr. Maria Maccecchini and Henry Hagopian III from Annovis Bio.
Hi, good morning. Good morning and welcome here. So I'm going to talk about Annovis Bio. We work on Alzheimer's and Parkinson's disease.
This is our disclosure.
And we are in Phase 3 with a drug that, in Phase 2, worked in Parkinson's disease. It actually improved movement, and it worked in Alzheimer's disease. It improved cognition.
As far as I know, we are the only company that has a drug that works in Alzheimer's and -- oh, I see. Can you turn this off? I have two microphones. Okay, that's -- so as far as I know, this is -- we are the only company that has a drug that works in Alzheimer's and Parkinson's and in animals,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
